glucuronic acid has been researched along with HIV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joshy, KS; Laly, AP; Nandakumar, K; Sabu, T; Snigdha, S; Susan, MA | 1 |
| Kim, YH; Lee, J; Lee, KY; Lee, SK; Tan, CY | 1 |
2 other study(ies) available for glucuronic acid and HIV
| Article | Year |
|---|---|
Encapsulation of zidovudine in PF-68 coated alginate conjugate nanoparticles for anti-HIV drug delivery.
Topics: Alginates; Amides; Anti-HIV Agents; Chitosan; Drug Carriers; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; HIV; HIV Infections; Humans; Nanoparticles; Zidovudine | 2018 |
Controlled delivery of heat shock protein using an injectable microsphere/hydrogel combination system for the treatment of myocardial infarction.
Topics: Alginates; Apoptosis; Cell Hypoxia; Cell Line; Cell Proliferation; Cell Survival; Delayed-Action Preparations; Glucuronic Acid; Heat-Shock Proteins; Hexuronic Acids; HIV; HSP27 Heat-Shock Proteins; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Lactic Acid; Microspheres; Molecular Chaperones; Myoblasts, Cardiac; Myocardial Infarction; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Recombinant Fusion Proteins; tat Gene Products, Human Immunodeficiency Virus | 2009 |